Abstract: The snappiness of the parasitic body diodes of SiC- MOSFETs lead to high voltage overshoots, often exceeding the physical limits of the chip technology. The impact of monolithic RC-snubber ...
R toolkit for enhanced downstream analysis of Taiji - Wang-lab-UCSD/Taiji2 ...
Andy Lupini, distinguished R&D staff member of ORNL’s Electron Microscopy and Microanalysis Group, and Kevin Roccapriore — on entrepreneurial leave from ORNL’s Data NanoAnalytics Group to launch the ...
Abstract: Accurate and timely air quality prediction is crucial for cities and individuals to effectively take necessary precautions against potential air pollution. Existing studies typically rely on ...
A novel combination of mRNA technology and immune modulation may offer a new strategy for treating allergic diseases, according to new research demonstrating enhanced immune tolerance and reduced ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...
Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
Background SIRT6 acts as a tumour suppressor in multiple cancers by regulating glucose and lipid metabolism, but its role in intrahepatic cholangiocarcinoma (ICC) remains unclear. Objective We ...
A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which the company claims has restored vision in monkeys, for ...
Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results